Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy

NCT06461377 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.

NCT NCT06461377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06461377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Phase
Phase 4
Overall status
Recruiting
Start date
June 13, 2024
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes with diabetic autonomic neuropathy (diagnosis), type 2 diabetes